Showing 1 - 3 results of 3 for search 'Rena Buckstein', query time: 0.01s Refine Results
  1. 1
    Should we move past erythropoietin-stimulating agent monotherapy in lower-risk myelodysplastic syndromes?

    Should we move past erythropoietin-stimulating agent monotherapy in lower-risk myelodysplastic syndromes? by Lee Mozessohn, Rena Buckstein

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Intensive versus less-intensive antileukemic therapy in older adults with acute myeloid leukemia: A systematic review.

    Intensive versus less-intensive antileukemic therapy in older adults with acute myeloid leukemia: A systematic review. by Yaping Chang, Gordon H Guyatt, Trevor Teich, Jamie L Dawdy, Shaneela Shahid, Jessica K Altman, Richard M Stone, Mikkael A Sekeres, Sudipto Mukherjee, Thomas W LeBlanc, Gregory A Abel, Christopher S Hourigan, Mark R Litzow, Laura C Michaelis, Shabbir M H Alibhai, Pinkal Desai, Rena Buckstein, Janet MacEachern, Romina Brignardello-Petersen

    Published 2021-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Advancing drug development in myelodysplastic syndromes

    Advancing drug development in myelodysplastic syndromes by Alain Mina, Kathy L. McGraw, Lea Cunningham, Nina Kim, Emily Y. Jen, Katherine R. Calvo, Lori A. Ehrlich, Peter D. Aplan, Guillermo Garcia-Manero, James M. Foran, Jacqueline S. Garcia, Amer M. Zeidan, Amy E. DeZern, Rami Komrokji, Mikkael A. Sekeres, Bart Scott, Rena Buckstein, Sara Tinsley-Vance, Amit Verma, Tanya Wroblewski, Steven Pavletic, Kelly Norsworthy

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: